ADVANCING OUR PIPELINE

ADVANCING OUR PIPELINE

Developing therapies for solid tumors and other diseases

Program
Indication
Preclinical
Phase 1a/1b
Phase 2
Phase 3
Preclinical
Phase 1a/1b
Phase 2
Phase 3
PLN-101095

αvβ8/αvβ1 inhibitor

Solid tumors
Solid tumors
Fortify logo
Preclinical
Phase 1a/1b
Phase 2
Phase 3
Muscle
Adipose tissue
Undisclosed
Muscle
Adipose tissue
Undisclosed

Expanding Possibilities

We will continue to evaluate additional indications to maximize the potential of our pipeline.

Our science
right arrow
A person working in a lab